Longevity clinics and practitioners exist to extend healthspan, not just lifespan. At the heart of this mission is mitochondrial function: these organelles influence energy production, cellular signalling, and many processes linked to ageing. mescreen™ offers a practical way to quantify mitochondrial efficiency and integrate it into personalised longevity protocols.

Rather than relying solely on standard blood tests and subjective questionnaires, you can incorporate an explicit mitochondrial assessment into baseline workups and ongoing reviews. This adds a new dimension to your understanding of each patient’s biological status and provides a central biomarker around which to structure interventions in nutrition, movement, sleep, stress, and advanced therapies.

Clients of longevity practices tend to be engaged, informed, and willing to invest in tools that offer deeper insight. mescreen™ fits this mindset perfectly: it is frontier science, made operationally simple. By retesting periodically, you can show how an individual’s mitochondrial health is evolving in response to protocols – a compelling way to demonstrate value and refine treatment plans.

Commercially, mescreen™ can be embedded in tiered longevity programmes, annual memberships, executive health checks, and bespoke concierge packages. It reinforces your clinic’s positioning at the cutting edge of personalised, preventative and performance medicine, while remaining practical to deploy.